PMID: 8603024Feb 1, 1996Paper

Heparin-induced skin lesions

British Journal of Haematology
T E Warkentin

Abstract

Six patients who developed heparin-induced skin lesions were tested for the presence of heparin-dependent, platelet-activating IgG irrespective of whether they developed thrombocytopenia. All six patients' sera contained potent heparin-dependent, platelet-activating IgG. However, only two of the six patients developed thrombocytopenia, and both of these patients developed thrombotic complications. One of the four patients who developed skin lesions without thrombocytopenia also developed a characteristic complication of heparin-induced thrombocytopenia (adrenal haemorrhagic infarction). These observations indicate that formation of heparin-dependent, platelet-activating IgG is a consistent feature of patients who developed heparin-induced skin lesions irrespective of whether thrombocytopenia occurs.

Citations

Mar 11, 1999·American Journal of Hematology·D Gailani, E P Reese
Sep 1, 1999·American Journal of Hematology·T E WarkentinD P Lillicrap
Oct 17, 1998·Clinical Reviews in Allergy & Immunology·G Arepally, D B Cines
Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Emmanuel de MaistreDominique Lasne
Feb 24, 2012·Intensive Care Medicine·Henry Thomas Stelfox, Barry Kushner
Feb 18, 2011·Journal of Thrombosis and Thrombolysis·Adam Cuker
Jul 3, 1999·European Journal of Obstetrics, Gynecology, and Reproductive Biology·F RobinR Taurelle
Sep 21, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·A A Taylor
Dec 20, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Lisa A HouriganG William Dec
Jul 10, 2003·Autoimmunity Reviews·Gowthami Arepally, Douglas B Cines
Nov 13, 2001·Reviews in Clinical and Experimental Hematology·A GreinacherV Kiefel
Jun 1, 2005·Seminars in Interventional Radiology·Stuart B ResnickNishita Kothary
Feb 20, 1997·The New England Journal of Medicine·R V McCloskey
Feb 9, 1999·Plastic and Reconstructive Surgery·E C SmootS R Deitcher
Jul 7, 2011·Current Opinion in Hematology·Adam Cuker
Oct 12, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·Z Khan, D K Watson
Mar 12, 1999·Annual Review of Medicine·T E Warkentin
Oct 6, 2005·Thrombosis Journal·Massimo Franchini
Nov 14, 2001·American Journal of Clinical Dermatology·J HarenbergC Bayerl
Oct 3, 2008·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Burcak Kilickiran AvciOsman Ozcebe
Apr 9, 2011·PharmacoEconomics·Natasha NanwaWilliam Geerts
Aug 9, 2003·Expert Opinion on Drug Safety·I JörgJ Harenberg
Mar 19, 2014·Pediatric Clinics of North America·Lucero Noguera-MorelAntonio Torrelo
Sep 17, 2010·Mayo Clinic Proceedings·Marc SchindewolfRalf J Ludwig
Aug 2, 2007·Hematology/oncology Clinics of North America·Theodore E Warkentin
Jul 31, 2007·Annales Françaises D'anesthèsie Et De Rèanimation·S PerbetJ Mantz
May 20, 2003·British Journal of Haematology·Theodore E Warkentin
Dec 2, 2014·Journal of the American Academy of Dermatology·Christine SchleichJoslyn S Kirby
Apr 29, 2006·British Journal of Haematology·David KeelingUNKNOWN Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology
Oct 30, 2008·Pharmacotherapy·Heather R Bream-Rouwenhorst, Ryan A Hobbs
Mar 1, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·S Sanchez-PolittaL Borradori
Feb 5, 2010·Journal of Thrombosis and Haemostasis : JTH·M SchindewolfE Lindhoff-Last
Oct 10, 2012·British Journal of Haematology·Henry WatsonUNKNOWN Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology
Mar 1, 2012·American Journal of Hematology·Theodore E Warkentin
Apr 21, 2010·Journal of Thrombosis and Haemostasis : JTH·T E Warkentin, L-A Linkins
Jan 28, 2010·American Journal of Surgery·Sandra BattistelliTommaso Gori
Mar 31, 1999·Baillière's Clinical Haematology·A Greinacher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Internal Medicine
Gustavo B F OliveiraComplications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators
British Journal of Haematology
P HorsewoodJohn G Kelton
© 2021 Meta ULC. All rights reserved